Making it Personal – Engaging the public through theatre
14 July 2025
Innovative public engagement project explores the intersection of cutting-edge science and the raw honesty of the stage.
Thelior Bio: rethinking gut health from the inside out
10 July 2025
A new spinout company, formed from research conducted at the MRC Translational Immune Discovery Unit, aims to develop a new class of therapies for patients with inflammatory bowel disease.
New tool allows researchers to track how mutations arise in tissues
3 July 2025
Researchers at the MRC Weatherall Institute of Molecular Medicine and the German Cancer Research Center (DKFZ) have developed a new method to analyse how our tissues evolve as we age.
Celebrating science, collaboration and excellence at WIMM Day 2025
1 July 2025
The MRC WIMM community gathered for its flagship annual event, WIMM Day, on Tuesday 24th June. Held at the Saïd Business School, the day showcased the breadth and impact of research across the institute and celebrated achievements in mentorship, public engagement and more.
New research reveals druggable target arising from chromosomal rearrangement in aggressive leukaemia
10 June 2025
Researchers at the University of Oxford have uncovered a potential new therapeutic target in a particularly aggressive and hard-to-treat form of leukaemia.
T cell responses to monkeypox play a part in protecting against infection
15 May 2025
A new study, led by researchers at the MRC TIDU in the MRC Weatherall Institute of Molecular Medicine, NDM's CAMS Oxford Institute, the Centre for Human Genetics, the Kennedy Institute and the Dunn School of Pathology, has found that specific T cells could have an impact on the long-term protective responses to future infection.
Study identifies key immune structures in the gut that may drive coeliac disease
6 May 2025
Researchers in Oxford have found structures of immune cells in the gut that may be driving the response to gluten in people with coeliac disease and could provide a target for future therapies.
Professor Andrew McMichael elected to the US National Academy of Sciences
6 May 2025
Four academics from the University of Oxford have been elected to the National Academy of Sciences in the US this year as international members, including former Institute Director Andrew McMichael.
RDM researchers edit new edition of seminal haematology textbook
1 May 2025
Professor Adam Mead is Editor-in-Chief and Graham Collins and Deborah Hay two of the editors for the eighth edition of this key reference work, now in its sixth decade.
New study finds common virus may improve skin cancer treatment outcomes
23 April 2025
A new study led by the Fairfax Group at the University of Oxford has revealed that a common and usually harmless virus may positively influence how skin cancer patients respond to current treatments.
Wellcome Career Development Award For Agne Antanaviciute
2 April 2025
Dr Agne Antanaviciute has won a Wellcome Career Development Award for her research investigating early-life immunity.
Technician Champion appointed in RDM
2 April 2025
Facility Manager Michalina Mazurczyk, based in the MRC Weatherall Institute of Molecular Medicine, has been appointed as Technician Champion for the second year.
Bannard Group receives Wellcome Discovery Award
25 March 2025
Professor Oliver Bannard has been awarded funding for an 8-year research programme investigating how our immune systems establish antibody-mediated immunity following vaccination and during infection.
New study reveals details of key immune mechanism
25 March 2025
An international collaboration, initiated by the Jackson Group at the MRC WIMM, has uncovered new information that could help in the development of drugs to block conditions such as autoimmunity and inflammation.
Ancient genomic linkage regulates red blood cell development
24 March 2025
A collaboration between the Drakesmith and Higgs Groups at the MRC WIMM has identified an ancient connection between metabolic and transcriptional control of erythropoiesis.